Literature DB >> 16904570

Keeping apples and oranges separate: reassessing clinical trials that use composite end points as their primary outcome.

Paul S Chan, Brahmajee K Nallamothu, Rodney A Hayward.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16904570     DOI： 10.1016/j.jacc.2006.05.034

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

1.  Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints.

Authors:  Geraldine Rauch; Meinhard Kieser; Harald Binder; Antoni Bayes-Genis; Antje Jahn-Eimermacher
Journal:  Clin Res Cardiol       Date:  2018-02-16       Impact factor: 5.460

2.  A systematic comparison of recurrent event models for application to composite endpoints.

Authors:  Ann-Kathrin Ozga; Meinhard Kieser; Geraldine Rauch
Journal:  BMC Med Res Methodol       Date:  2018-01-04       Impact factor: 4.615
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.